Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage

9 July 2019 - A unit of Novartis said on Tuesday it would make partner Adamis Pharmaceuticals Corp’s emergency allergy ...

Read more →

ICER's final report on peanut allergy treatments: clinical evidence does not yet demonstrate that long-term benefits of desensitisation outweigh short-term risks

10 July 2019 - Independent appraisal committee highlights importance of non-clinical benefits and contextual considerations when evaluating AR101 and Viaskin Peanut. ...

Read more →

Amazon’s Alexa to offer NHS health care advice

10 July 2019 - The UK Government has announced that the NHS has plans to collaborate with Amazon to provide ...

Read more →

FDA approves Katerzia, the first and only amlodipine oral suspension for paediatric patients 6 years of age and older

10 July 2019 - Azurity Pharmaceuticals announced today that the U.S. FDA has approved Katerzia (amlodipine) 1 mg/mL oral suspension, ...

Read more →

FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma

10 July 2019 - The U.S. FDA has accepted for review the biologics license application for isatuximab for the treatment ...

Read more →

Why disclosing drug prices in TV ads won't lower costs

10 July 2019 - A federal judge blocked President Donald Trump’s order to force drugmakers to disclose the list prices ...

Read more →

Drug makers boost prices up to 909%, defying political pressure

10 July 2019 - Bipartisan efforts to lower drug prices in Washington have not prevented drugmakers from going about their ...

Read more →

Cellectar receives FDA fast track designation for CLR 131 in diffuse large B-cell lymphoma

9 July 2019 - Cellectar Biosciences today announced the U.S. FDA has granted fast track designation for CLR 131 in relapsed ...

Read more →

Vaccine crisis leaves Australia’s immunisation record in tatters

9 July 2019 - Thousands of Australians are dying from the flu and meningococcal because lifesaving vaccines are not being approved, ...

Read more →

CMS’s international pricing model for Medicare Part B drugs: implementation issues

9 July 2019 - For many years, Americans have paid significantly more than the rest of the world for prescription drugs. ...

Read more →

'Amazing' gene-silencing drugs reach NHS

9 July 2019 - A new form of medicine called "gene-silencing" has been approved for use by the NHS in ...

Read more →

ViiV Healthcare announces start of first-ever study to identify and evaluate approaches to implementing its once-monthly injectable HIV treatment in clinical practice

9 July 2019 - The long-acting injectable regimen has been granted priority review status by the FDA, with a target approval ...

Read more →

GSK welcomes the UK trial of subscription-style payment system for pharma companies to incentivise creation of new antibiotics

9 July 2019 - GSK is committed to tackling antimicrobial resistance as part of a sustained, multi-stakeholder response to this global ...

Read more →

FDA accepts Merck’s supplemental biologics license applications for Keytruda (pembrolizumab) six-week dosing schedule for melanoma and multiple other indications

9 July 2019 - Merck today announced that the U.S. FDA has accepted for review six supplemental biologics license applications to ...

Read more →

FDA leverages private sector technology-based tools in its embrace of real world evidence

9 July 2019 - Following decades of near total reliance on randomised clinical trial data, the U.S. FDA (with a ...

Read more →